secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0001809519-23-000055
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx responds to CVS Health's new pharmacy reimbursement model, highlights existing acquisition-cost pricing
--------------------------------------------------------------------------------

- GoodRx already hosts discount card pricing agreements informed by acquisition cost-based pricing at CVS Pharmacy and other key retailers.
- Company plans to continue implementing acquisition cost-based approach with retail partners pursuing this model.
- Sees its hybrid pharmacy contracting strategy as well positioned for evolving reimbursement models.
- Disclosure follows CVS Health's recent announcement of a new pharmacy reimbursement formula based on drug cost plus markup and fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951923000055/0001809519-23-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951923000055/gdrx-20231205.htm
  HTML page:      https://secwatch.observer/filing/0001809519-23-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer